September 01, 2025 Initial DIAMOND Results Support OCS-01 Efficacy Breakthrough results in diabetic macular edema treatment presented at Euretina 2025 highlight significant visual gains with OCS-01 eye drops. Retinal Physician
February 26, 2025 Integration of Vision Services Remains an Unmet Need in FQHCs Telemedicine, funding, and provider partnerships can help, researchers say. Conexiant
April 02, 2025 GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities. Conexiant
June 27, 2025 Also in the News… The Ophthalmologist brings you the top news stories and studies of the week The Ophthalmologist
August 04, 2025 Keeping an Eye on Blood Sugar Status Researchers advocate for proactive diabetes management that protects ocular health beyond retinopathy prevention The Ophthalmologist
November 08, 2024 Is Intravenous Methylprednisolone Efficacious for Visual Complications of GCA? While timely treatment is essential to protect vision, the researchers found no visual acuity benefit with IVMP. Conexiant
December 16, 2024 Does Ozempic Double Eye Disease Risk? Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients. Reuters
November 07, 2024 Diabetes Affects 1 in 6 US Adults: CDC Data In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals. Conexiant
July 03, 2024 Semaglutide Linked to Vision-Threatening Eye Disorder New study finds that 8.9% of type 2 diabetes patients taking semaglutide experienced NAION, compared to 1.8% of those on non-GLP-1 diabetes drugs. Reuters